Label Value
DOI 10.1186/2051-1426-3-S2-P155
TITLE Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)
TYPE article
Service Status Date Last Checked
Scopus No 2021-04-11T02:06:51.774634
Web of Science No 2021-04-11T03:29:36.685935
Compendex No 2019-12-18T13:33:20.419016